July 26, 2024 C-Path’s Alzheimer’s Consortium Unveils Seminal Methodology to Enhance Alzheimer’s Clinical Trials Using Imaging Biomarkers C-Path is proud to announce the publication of a new study in the journal Alzheimer’s & Dementia...
July 23, 2024 C-Path’s Lysosomal Disease Consortium Welcomes Chiesi Group as its Newest Member C-Path's Critical Path for Lysosomal Diseases (CPLD) Consortium today proudly announced the addition of Chiesi Group...
July 23, 2024 DATAcc by DiMe Expands Library of Digital Measurement Products to Include Parkinson’s Disease Today, the Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe), in partnership....
July 18, 2024 BYOD: A Guide for Successful Implementation Join us on Thursday, July 18, for an in-depth look at the key considerations around the use of Bring Your Own Device (BYOD)...
July 18, 2024 The Influential Role of Patient Advocacy Groups in Registry Data Efforts We are excited to invite you to our upcoming webinar, "The Influential Role of Patient Advocacy Groups in Registry Data...
July 1, 2024 Lane United Football Club’s ‘United Against Cancer’ Game to Support Sarcoma Community The event, scheduled for Wed., July 3, is supported by C-Path's CDRC, xCures and hummel as sponsors.
June 24, 2024-June 25, 2024 C-Path’s Stephenson to Serve as Co-panelist for FNIH Digital Technologies Summit C-Path's Executive Director, Critical Path for Parkinson's (CPP) Consortium, Diane Stephenson will join as a...
June 20, 2024 Hidden in Plain Sight: Autosomal Dominant Tubulointerstitial Kidney Disease C-Path's Rare and Orphan Disease Programs is excited to have Dr. Anthony Bleyer present it's June webinar...
June 20, 2024 C-Path Partners with FARA to Fortify RDCA-DAP and Further Accelerate Drug Development with new Friedreich’s Ataxia Data C-Path announced the targeted integration of additional Friedreich’s ataxia...
June 20, 2024 C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development C-Path, a leader in forming collaborations that accelerate drug development, and Centogene N.V. (Nasdaq: CNTG)...